Autologous Tumor-Infiltrating Lymphocyte (GTE-001 Injection ) for Treatment of Patients With Advanced Lung Adenocarcinoma

Summary

This study is a Multiple centers, open design aimed at evaluating the safety,efficacy and Production feasibility of Autologous Tumor-Infiltrating Lymphocyte (GTE-001 injection ) for treatment of patients with Advanced lung adenocarcinoma,And evaluate potential biomarkers related to GTE-001 activity.

Timeline

Start

2024-07-18

Primary completion

2024-08-27

Completion

2024-08-27

Outcome

Outcome not reported

Stopped (Business): “The study was terminated from a business perspective.”

Drugs

Indications